# Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy

> **NCT07715903** · PHASE1 · NOT_YET_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 20 (estimated)

## Conditions studied

- Colorectal Neoplasms
- Neoplasms
- Intrahepatic Cholangiocarcinoma
- Adrenocortical Carcinoma
- Metastasis, Neoplasm

## Interventions

- **DRUG:** Carfilzomib

## Key facts

- **NCT ID:** NCT07715903
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-14
- **Primary completion:** 2029-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715903, "Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07715903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*